ECSP16090450A - HUMANIZED ANTIBODIES AGAINST THE CELLULAR ADHESION MOLECULE RELATED TO CARCINOEMBRIONIC ANTIGEN 1 (CEACAM1) - Google Patents

HUMANIZED ANTIBODIES AGAINST THE CELLULAR ADHESION MOLECULE RELATED TO CARCINOEMBRIONIC ANTIGEN 1 (CEACAM1)

Info

Publication number
ECSP16090450A
ECSP16090450A ECIEPI201690450A ECPI201690450A ECSP16090450A EC SP16090450 A ECSP16090450 A EC SP16090450A EC IEPI201690450 A ECIEPI201690450 A EC IEPI201690450A EC PI201690450 A ECPI201690450 A EC PI201690450A EC SP16090450 A ECSP16090450 A EC SP16090450A
Authority
EC
Ecuador
Prior art keywords
humanized antibodies
ceacam1
antibodies against
adhesion molecule
cellular adhesion
Prior art date
Application number
ECIEPI201690450A
Other languages
Spanish (es)
Inventor
Gal Markel
Rona Ortenberg
Yair Sapir
Ilana Mandel
Timothy David Jones
Jacob Schachter
Tehila Ben-Moshe
Robert George E Holgate
Francis Joseph Carr
Original Assignee
Ccam Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ccam Therapeutics Ltd filed Critical Ccam Therapeutics Ltd
Publication of ECSP16090450A publication Critical patent/ECSP16090450A/en

Links

Abstract

Se proporcionan anticuerpos humanizados, capaces de unión específica a moléculas de CEACAM1 humana que contienen mutaciones restauradoras de humano a murino en regiones variables distintas de CDR, y sus secuencias codificadoras de polinucleótidos; también se proporcionan composiciones farmacéuticas que comprenden estos anticuerpos, así como sus métodos de su uso para tratar y diagnosticar cáncer y otras condiciones.Humanized antibodies are provided, capable of specific binding to human CEACAM1 molecules containing human to murine restorative mutations in variable regions other than CDRs, and their polynucleotide coding sequences; Pharmaceutical compositions comprising these antibodies are also provided, as well as methods of their use to treat and diagnose cancer and other conditions.

ECIEPI201690450A 2014-04-27 2016-11-24 HUMANIZED ANTIBODIES AGAINST THE CELLULAR ADHESION MOLECULE RELATED TO CARCINOEMBRIONIC ANTIGEN 1 (CEACAM1) ECSP16090450A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461984786P 2014-04-27 2014-04-27

Publications (1)

Publication Number Publication Date
ECSP16090450A true ECSP16090450A (en) 2017-06-30

Family

ID=72643836

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201690450A ECSP16090450A (en) 2014-04-27 2016-11-24 HUMANIZED ANTIBODIES AGAINST THE CELLULAR ADHESION MOLECULE RELATED TO CARCINOEMBRIONIC ANTIGEN 1 (CEACAM1)

Country Status (1)

Country Link
EC (1) ECSP16090450A (en)

Similar Documents

Publication Publication Date Title
DOP2016000282A (en) HUMANIZED ANTIBODIES AGAINST THE CELLULAR ADHESION MOLECULE RELATED TO CARCINOEMBRIONIC ANTIGEN 1 (CEACAM1)
NI201700012A (en) PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE
PE20210287A1 (en) ANTI-CD25 FOR THE DEPLETION OF SPECIFIC TUMOR CELLS
PH12018501220A1 (en) Bispecific molecules having immunoreactivity with pd-1 and ctla-4, and methods of use thereof
MX2020012797A (en) Anti-pvrig/anti-tigit bispecific antibodies and methods of use.
EA201892193A1 (en) CHEMICAL RECEPTORS TO FLT3 AND METHODS OF THEIR APPLICATION
EA201892362A1 (en) AGONISTIC ANTIBODIES THAT ARE BINDING HUMAN CD40, AND THEIR OPTIONS
SA517381703B1 (en) Anti-C10orf54 Antibodies And Uses Thereof
EA201690167A1 (en) HUMANIZED OR CHEMICAL ANTIBODIES TO CD3
CO2017005650A2 (en) Anti-interleukin-33 antibodies
CO2019001246A2 (en) Anti-PD-1 antibodies, a production method and a method for its use
EA201890305A1 (en) HUMANIZED OR CHIMERIC CD3 ANTIBODIES
EA201591091A1 (en) Antigen-binding proteins for BCMA
EA201790060A1 (en) BISPECIFIC CD33- and CD3-BINDING PROTEINS
EA201791270A1 (en) MODIFIED APRIL-BINDING ANTIBODIES
EA201291039A1 (en) HUMAN CD27 ANTIBODIES AND THEIR APPLICATION
PH12016501366A1 (en) Novel anti-baff antibodies
EA202190609A1 (en) ANTIBODIES AGAINST HLA-G, COMPOSITIONS CONTAINING ANTIBODIES AGAINST HLA-G, AND METHODS OF APPLICATION ANTIBODIES AGAINST HLA-G
EA201792581A1 (en) METHODS OF APPLICATION OF BISPECIFIC CD33- and CD3-BINDING PROTEINS
MX2021000392A (en) Anti-mesothelin antibodies.
EA202191785A1 (en) ANTIBODIES TO CTLA4 AND METHODS OF THEIR APPLICATION
BR112018010279A2 (en) new anti-emr2 antibodies and methods of use
MX2021004732A (en) Heavy chain antibodies binding to cd38.
NZ730247A (en) Antibodies to ticagrelor and methods of use
BR112018012884A2 (en) new anti-mmp16 antibodies and methods of use